Form 4: TriSalus Life Sciences Executive Acquires and Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Bryan F. Cox, Chief of Research at TriSalus Life Sciences, reports acquiring and disposing of common stock on May 19, 2025, to cover tax liabilities associated with vested Restricted Stock Units (RSUs).
Summary
- On May 19, 2025, Bryan F. Cox, Chief of Research at TriSalus Life Sciences, acquired 15,722 shares of common stock at $5.18 per share due to the vesting of Restricted Stock Units (RSUs).
- Simultaneously, Cox disposed of 4,764 shares at $5.18 per share to cover the tax liability associated with the vested RSUs.
- Following these transactions, Cox directly owns 119,415 shares of TriSalus Life Sciences common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations.
Positives
- The vesting of RSUs indicates a form of compensation and alignment of the executive's interests with the company's performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/19/2025 | Date of stock acquisition and disposal by Bryan F. Cox. |
| 05/21/2025 | Date of signature by Attorney-in-Fact, Mary Szela. |
Keywords
TriSalus Life Sciences, Bryan F. Cox, Form 4, TLSI, Insider Trading, Restricted Stock Units, RSUs, Beneficial Ownership, Chief of Research, Stock Acquisition, Stock Disposal, Tax Liability
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.